Search results
Results from the WOW.Com Content Network
AOH1996 is an experimental anticancer medication which acts as a small molecule inhibitor of proliferating cell nuclear antigen (PCNA) and is in Phase I clinical trials at City of Hope as of August 2023 for the treatment of solid tumors. [1] [2] [3] [4]
The Dragonfly project was an Internet search engine prototype created by Google that was designed to be compatible with China's state censorship provisions. [ 1 ] [ 2 ] [ 3 ] The public learned of Dragonfly's existence in August 2018, when The Intercept leaked an internal memo written by a Google employee about the project.
The deal values G1 Therapeutics at a 68% premium above its final closing price. G1 has spent years developing its flagship drug trilaciclib, sold under the brand name Cosela.
TOKYO (Reuters) -Drugmaker Merck will pay Daiichi Sankyo $5.5 billion to jointly develop three of its candidate cancer drugs, they said, in a deal that could be worth up to $22 billion to the ...
(Reuters) -Eli Lilly and Co will buy Point Biopharma Global for $1.4 billion, the companies said on Tuesday, gaining access to experimental therapies that enable precise targeting of cancer.
Kanzius, self-taught, stated that he was motivated to research the subject of cancer treatment by his own experiences undergoing chemotherapy for treatment of non-Hodgkin's lymphoma. [ 4 ] [ 5 ] He died of B-cell leukemia with complications from pneumonia without seeing FDA approval and commercialization of his invention.
The U.S. Food and Drug Administration in 2021 delayed its review for the drug as a second-line treatment in patients with esophageal cancer due to COVID-19 curbs that prevented the regulator from ...
The American National Comprehensive Cancer Network's official guidelines list TTFields as an option for the treatment of recurrent glioblastoma, but note substantial disagreement among the members of the expert panel making this recommendation. [2] High-quality evidence for the efficacy of TTFields in oncology is limited.